Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.9300-0.0200 (-1.03%)
At close: 04:00PM EDT
1.9400 +0.01 (+0.52%)
After hours: 04:56PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
Total Revenue
0
0
0
Operating Expense
10,424
7,704
11,833
Operating Income
-10,424
-7,704
-11,833
Net Non Operating Interest Income Expense
-582.537
-821.366
-516.45
Other Income Expense
-408.4
441.581
-333.658
Pretax Income
-11,414
-8,084
-12,683
Net Income Common Stockholders
-21,430
-8,084
-12,683
Diluted NI Available to Com Stockholders
-21,430
-8,084
-12,683
Basic EPS
-
-0.89
-1.40
Diluted EPS
-
-0.89
-1.40
Basic Average Shares
-
9,082
9,082
Diluted Average Shares
-
9,082
9,082
Total Operating Income as Reported
-10,424
-7,704
-11,833
Total Expenses
10,424
7,704
11,833
Net Income from Continuing & Discontinued Operation
-11,414
-8,084
-12,683
Normalized Income
-11,006
-8,526
-12,350
Interest Expense
582.537
821.366
516.45
Net Interest Income
-582.537
-821.366
-516.45
EBIT
-10,832
-7,263
-12,167
EBITDA
-10,822
-
-
Reconciled Depreciation
10.4
10.4
10.4
Net Income from Continuing Operation Net Minority Interest
-11,414
-8,084
-12,683
Total Unusual Items Excluding Goodwill
-408.4
441.581
-333.658
Total Unusual Items
-408.4
441.581
-333.658
Normalized EBITDA
-10,413
-7,694
-11,823
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
Advertisement
Advertisement